Nofi Michael
SEC insider (Form 3/4/5 filer). CIK 0001705477. Chief Financial Officer at Edgewise Therapeutics, Inc. (EWTX) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in BOULDER, CO.
Companies Nofi Michael has filed insider reports for
- Edgewise Therapeutics, Inc. (EWTX): Officer, Chief Financial Officer
- SpringWorks Therapeutics, Inc. (SWTX): Officer, Chief Accounting Officer
Nofi Michael
CIK: 0001705477
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
48.8K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectRestricted Stock Units
24.4K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
48.8K shares- - Nov 10, 2025EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Options (Right to buy)
262.5K shares- - Nov 10, 2025EWTX
Edgewise Therapeutics, Inc.
AwardDirectRestricted Stock Units
43.8K shares- - Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DispositionDirect30.6K shares- - Jan 10, 2025SWTX
SpringWorks Therapeutics, Inc.
AwardDirect6.9K shares- - Jan 6, 2025SWTX
SpringWorks Therapeutics, Inc.
Tax PaymentDirect1K shares at avg. $38.86$39K - Jan 5, 2025SWTX
SpringWorks Therapeutics, Inc.
Tax PaymentDirect1.6K shares at avg. $38.19$62K - Jan 4, 2025SWTX
SpringWorks Therapeutics, Inc.
Tax PaymentDirect2.4K shares at avg. $38.19$91K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 |  EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 48,750 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Restricted Stock Units | 24,375 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 48,750 | - | - | Direct |
| Nov 10, 2025 | EWTX Edgewise Therapeutics, Inc. | Award Stock Options (Right to buy) | 262,500 | - | - | Direct |
| Nov 10, 2025 | EWTX Edgewise Therapeutics, Inc. | Award Restricted Stock Units | 43,750 | - | - | Direct |
| Jul 1, 2025 |  SWTX SpringWorks Therapeutics, Inc. | Disposition | 30,623 | - | - | Direct |
| Jan 10, 2025 | SWTX SpringWorks Therapeutics, Inc. | Award | 6,929 | - | $0 | Direct |
| Jan 6, 2025 | SWTX SpringWorks Therapeutics, Inc. | Tax Payment | 1,009 | $38.86 | $39,210 | Direct |
| Jan 5, 2025 | SWTX SpringWorks Therapeutics, Inc. | Tax Payment | 1,636 | $38.19 | $62,479 | Direct |
| Jan 4, 2025 | SWTX SpringWorks Therapeutics, Inc. | Tax Payment | 2,388 | $38.19 | $91,198 | Direct |
1-10 of 10 transactions